Skip to content

Evaluation of D-chiro-inositol Treatments

Evaluation of the Effects of D-chiro-inositol in Female Healthy Volunteer

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05448378
Enrollment
10
Registered
2022-07-07
Start date
2022-06-04
Completion date
2022-09-16
Last updated
2022-09-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Inositol, Testosterone, Insulin, Ovulation, Asprosin

Brief summary

Healthy women will take tablets containing 600 mg D-chiro-inositol twice per day for one month. We will evaluate metabolic and hormonal.parameters, as insulienmia, glycemia, estradiol, testosterone.

Interventions

DIETARY_SUPPLEMENTD-chiro-inositol

D-chiro-inositol 600 mg twice per day on an empty stomach for one month

Sponsors

Lo.Li.Pharma s.r.l
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Intervention model description

Human healthy women

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 50 Years
Healthy volunteers
Yes

Inclusion criteria

* Good state of health; * Regular menstrual cycle.

Exclusion criteria

* pregnancy; * delivery in the previous 6 months; * currently breastfeeding; * menopause; * alcohol or drug abuse; * insulin resistance defined as HOMA-IR index greater than or equal to 2.5; * other medical morbidities, such as hypertension, PCOS, or diabetes; * oligomenorrhea or amenorrhea; * current treatment with corticosteroids or hormones (oral contraceptives, estrogensic, progestogensin); * use of GnRH analogues, SERMs, or SPRMs within the previous 6 months.

Design outcomes

Primary

MeasureTime frameDescription
Testosterone30 daysSerum values of testosterone

Secondary

MeasureTime frameDescription
Glycemia30 daysSerum values of glucose
Insulinemia30 daysSerum values of insulin
HOMA-IR index30 daysModel of assessment for insulin resistance
FSH30 daysSerum values of FSH
BMI30 daysbody-mass index
Estradiol30 daysSerum values of estradiol
DHEAS30 daysSerum values of DHEAS
Asprosin30 daysSerum values of asprosin
LH30 daysSerum values of LH

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026